These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35575946)

  • 1. Patient-specific dosimetry adapted to variable number of SPECT/CT time-points per cycle for [Formula: see text]Lu-DOTATATE therapy.
    Vergnaud L; Giraudet AL; Moreau A; Salvadori J; Imperiale A; Baudier T; Badel JN; Sarrut D
    EJNMMI Phys; 2022 May; 9(1):37. PubMed ID: 35575946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personalized dosimetry of
    Carter LM; Ocampo Ramos JC; Kesner AL
    Biomed Phys Eng Express; 2021 Aug; 7(5):. PubMed ID: 34271565
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of voxel S-value methods for personalized voxel-based dosimetry of
    Kim KM; Lee MS; Suh MS; Selvam HSMS; Tan TH; Cheon GJ; Kang KW; Lee JS
    Med Phys; 2022 Mar; 49(3):1888-1901. PubMed ID: 35014699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Pipeline for Automated Voxel Dosimetry: Application in Patients with Multi-SPECT/CT Imaging After
    Dewaraja YK; Mirando DM; Peterson AB; Niedbala J; Millet JD; Mikell JK; Frey KA; Wong KK; Wilderman SJ; Nelson AS
    J Nucl Med; 2022 Nov; 63(11):1665-1672. PubMed ID: 35422445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simplified image-based dosimetry using planar images and patient-specific S-values.
    Kim KM; Suh M; Cheon GJ; Lee MS; Lee JS
    Med Phys; 2024 Aug; 51(8):5708-5721. PubMed ID: 38340367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific Uptake in the Bone Marrow Causes High Absorbed Red Marrow Doses During [
    Hemmingsson J; Svensson J; Hallqvist A; Smits K; Johanson V; Bernhardt P
    J Nucl Med; 2023 Sep; 64(9):1456-1462. PubMed ID: 37290797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A radiomic- and dosiomic-based machine learning regression model for pretreatment planning in
    Plachouris D; Eleftheriadis V; Nanos T; Papathanasiou N; Sarrut D; Papadimitroulas P; Savvidis G; Vergnaud L; Salvadori J; Imperiale A; Visvikis D; Hazle JD; Kagadis GC
    Med Phys; 2023 Nov; 50(11):7222-7235. PubMed ID: 37722718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SPECT/CT Image-Derived Absorbed Dose to Red Marrow Correlates with Hematologic Toxicity in Patients Treated with [
    Blakkisrud J; Peterson AB; Wildermann SJ; Kingkiner G; Wong KK; Wang C; Frey KA; Stokke C; Dewaraja YK
    J Nucl Med; 2024 May; 65(5):753-760. PubMed ID: 38548350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3D Monte Carlo bone marrow dosimetry for Lu-177-PSMA therapy with guidance of non-invasive 3D localization of active bone marrow via Tc-99m-anti-granulocyte antibody SPECT/CT.
    Gosewisch A; Ilhan H; Tattenberg S; Mairani A; Parodi K; Brosch J; Kaiser L; Gildehaus FJ; Todica A; Ziegler S; Bartenstein P; Böning G
    EJNMMI Res; 2019 Aug; 9(1):76. PubMed ID: 31414241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dosimetry procedure for organs-at-risk in
    Marin G; Vanderlinden B; Karfis I; Guiot T; Wimana Z; Reynaert N; Vandenberghe S; Flamen P
    Phys Med; 2018 Dec; 56():41-49. PubMed ID: 30527088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone Marrow Absorbed Doses and Correlations with Hematologic Response During
    Hagmarker L; Svensson J; Rydén T; van Essen M; Sundlöv A; Gleisner KS; Gjertsson P; Bernhardt P
    J Nucl Med; 2019 Oct; 60(10):1406-1413. PubMed ID: 30902877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of methods for adapting [Formula: see text] dose-voxel-kernels to tissue inhomogeneities.
    Götz T; Schmidkonz C; Lang EW; Maier A; Kuwert T; Ritt P
    Phys Med Biol; 2019 Dec; 64(24):245011. PubMed ID: 31766045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy and uncertainty analysis of reduced time point imaging effect on time-integrated activity for
    Peterson AB; Mirando DM; Dewaraja YK
    EJNMMI Res; 2023 Jun; 13(1):57. PubMed ID: 37306783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of cyclic changes in pharmacokinetics and absorbed dose in pediatric neuroblastoma patients receiving [
    Malcolm JC; Falzone N; Gains JE; Aldridge MD; Mirando D; Lee BQ; Gaze MN; Vallis KA
    EJNMMI Phys; 2022 Mar; 9(1):24. PubMed ID: 35347483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of patient dosimetry in the clinical practice after targeted radiotherapy using [
    Santoro L; Mora-Ramirez E; Trauchessec D; Chouaf S; Eustache P; Pouget JP; Kotzki PO; Bardiès M; Deshayes E
    EJNMMI Res; 2018 Nov; 8(1):103. PubMed ID: 30498938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep transformer-based personalized dosimetry from SPECT/CT images: a hybrid approach for [
    Mansouri Z; Salimi Y; Akhavanallaf A; Shiri I; Teixeira EPA; Hou X; Beauregard JM; Rahmim A; Zaidi H
    Eur J Nucl Med Mol Imaging; 2024 May; 51(6):1516-1529. PubMed ID: 38267686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-dimensional Monte Carlo-based voxel-wise tumor dosimetry in patients with neuroendocrine tumors who underwent
    Goetz TI; Lang EW; Prante O; Maier A; Cordes M; Kuwert T; Ritt P; Schmidkonz C
    Ann Nucl Med; 2020 Apr; 34(4):244-253. PubMed ID: 32114682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-Time-Point Renal Dosimetry Using Nonlinear Mixed-Effects Modeling and Population-Based Model Selection in [
    Hardiansyah D; Yousefzadeh-Nowshahr E; Kind F; Beer AJ; Ruf J; Glatting G; Mix M
    J Nucl Med; 2024 Apr; 65(4):566-572. PubMed ID: 38423787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of Absorbed Doses of Indigenously Produced "Direct-route" Lutetium-177-[
    Kamaldeep ; Loharkar S; Das T; Basu S; Banerjee S
    Cancer Biother Radiopharm; 2022 Apr; 37(3):214-225. PubMed ID: 34910891
    [No Abstract]   [Full Text] [Related]  

  • 20. Dosimetry for (177)Lu-DKFZ-PSMA-617: a new radiopharmaceutical for the treatment of metastatic prostate cancer.
    Delker A; Fendler WP; Kratochwil C; Brunegraf A; Gosewisch A; Gildehaus FJ; Tritschler S; Stief CG; Kopka K; Haberkorn U; Bartenstein P; Böning G
    Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):42-51. PubMed ID: 26318602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.